ORLANDO, FLORIDA – Kids Beating Cancer is pleased to announce the continued support of pediatric oncology research by granting $200,000 to Dr. Margaret Chou of the Children’s Hospital of Philadelphia (CHOP). This grant is in addition to a previously awarded grant of $100,000, making the total support from Kids Beating Cancer for Dr. Chou’s research $300,000. Dr. Chou’s research focuses on Ewing Sarcoma (ES), which is the second most common bone cancer in children. This research is significant because survival rates for ES have not improved for decades. Despite the success of immunotherapy for other types of cancer, there have been no successful immunotherapy clinical trials for ES. Dr. Chou’s research at CHOP has identified a key factor which will be utilized to develop a novel immunotherapy targeted for ES. In addition to her role as principal investigator at CHOP, Dr. Chou is an Associate Professor at the Perelman School of Medicine at the University of Pennsylvania.
“There are still too many pediatric cancers that do not have improved outcomes and it is only through funding research that new discoveries will be found” states Margaret Guedes, President, Founder & CEO of Kids Beating Cancer who founded the organization after the loss of her son to leukemia.
Kids Beating Cancer is dedicated to ending childhood cancer through research grants supporting innovative, novel research projects that have the greatest potential for advancement into promising life-saving treatments for children with cancer. Kids Beating Cancer was founded in 1992 with the mission to provide access to lifesaving treatments to children diagnosed with cancer and fund pediatric cancer research, while supporting children and their families throughout the journey to a cure. Kids Beating Cancer has raised $29 million to fund life-saving programs for children and their families.
The Children’s Hospital of Philadelphia is the nation’s first hospital dedicated solely to the care of children. For 100 years, the research at CHOP has propelled innovations which have led to breakthrough treatments in pediatric medicine.